rs201787275
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 8P and 1B. PP5_Very_StrongBP4
The NM_183065.4(TMEM107):c.*759C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00199 in 761,870 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.0017 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0021 ( 3 hom. )
Consequence
TMEM107
NM_183065.4 3_prime_UTR
NM_183065.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.65
Genes affected
TMEM107 (HGNC:28128): (transmembrane protein 107) This gene encodes a transmembrane protein and component of the primary cilia transition zone. The encoded protein regulates ciliogenesis and ciliary protein composition. Human fibroblasts expressing a mutant allele of this gene exhibit reduced numbers of cilia, altered cilia length, and impaired sonic hedgehog signaling. In human patients, different mutations in this gene cause different ciliopathies, including Meckel-Gruber syndrome and orofaciodigital syndrome. [provided by RefSeq, May 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
PP5
Variant 17-8173444-G-A is Pathogenic according to our data. Variant chr17-8173444-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 265788.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-8173444-G-A is described in Lovd as [Pathogenic].
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.29). . Strength limited to SUPPORTING due to the PP5.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM107 | NM_183065.4 | c.*759C>T | 3_prime_UTR_variant | 5/5 | ENST00000437139.7 | NP_898888.1 | ||
SNORD118 | NR_033294.2 | downstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM107 | ENST00000437139.7 | c.*759C>T | 3_prime_UTR_variant | 5/5 | 1 | NM_183065.4 | ENSP00000402732 | P1 | ||
TMEM107 | ENST00000449985.6 | c.*808C>T | 3_prime_UTR_variant | 2/2 | 1 | ENSP00000404753 | ||||
SNORD118 | ENST00000363593.1 | downstream_gene_variant |
Frequencies
GnomAD3 genomes AF: 0.00172 AC: 261AN: 152160Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
261
AN:
152160
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00196 AC: 454AN: 231218Hom.: 2 AF XY: 0.00201 AC XY: 256AN XY: 127578
GnomAD3 exomes
AF:
AC:
454
AN:
231218
Hom.:
AF XY:
AC XY:
256
AN XY:
127578
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00206 AC: 1254AN: 609592Hom.: 3 Cov.: 0 AF XY: 0.00204 AC XY: 680AN XY: 333104
GnomAD4 exome
AF:
AC:
1254
AN:
609592
Hom.:
Cov.:
0
AF XY:
AC XY:
680
AN XY:
333104
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00171 AC: 260AN: 152278Hom.: 0 Cov.: 33 AF XY: 0.00150 AC XY: 112AN XY: 74466
GnomAD4 genome
AF:
AC:
260
AN:
152278
Hom.:
Cov.:
33
AF XY:
AC XY:
112
AN XY:
74466
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
5
AN:
3478
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Leukoencephalopathy with calcifications and cysts Pathogenic:4
Pathogenic, no assertion criteria provided | clinical testing | Laboratory of Neurogenetics and Neuroinflammation, Institut Imagine | Apr 06, 2020 | - - |
Pathogenic, criteria provided, single submitter | research | HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology | Aug 25, 2023 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 10, 2016 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen | Jan 03, 2024 | - - |
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jun 15, 2022 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | SNORD118: PM3:Strong, PM2:Supporting, PS3:Supporting - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 03, 2024 | Functional studies provide conflicting evidence, with one study suggesting this variant alters processing of the precursor U8 snoRNAs while another study suggests this variant is functional (PMID: 27571260, 32359472); Variant in a snoRNA that alters a C:G Watson-Crick base pair to a U:G wobble base pair in the 3' extension (PMID: 32359472); This variant is associated with the following publications: (PMID: 32359472, 33029936, 27571260, 34426522, 37761957, 36697224, 34937159, 34986804, 34220662, 32400930, 34380746, 31521395, 32358219, 31912665) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at